Gynecologic Oncology

Gynecological Tumors in Hereditary Nonpolyposis Colorectal Cancer: We Know They Are Common-Now What?
pp. 221-222(2)
Authors: Lu K.H.; Broaddus R.R.

The Clinical Features of Ovarian Cancer in Hereditary Nonpolyposis Colorectal Cancer
pp. 223-228(6)
Authors: Watson P.; Butzow R.; Lynch H.T.; Mecklin J.-P.; Jarvinen H.J.; Vasen H.F.A.; Madlensky L.; Fidalgo P.; Bernstein I.; International Collaborative Group on HNPCC

Transcriptional Targeting for Ovarian Cancer Gene Therapy
pp. 229-237(9)
Authors: Casado E.; Nettelbeck D.M.; Gomez-Navarro J.; Hemminki A.; Gonzalez Baron M.; Siegal G.P.; Barnes M.N.; Alvarez R.D.; Curiel D.T.

Cell Cycle Aberrations in the Pathogenesis of Squamous Cell Carcinoma of the Uterine Cervix
pp. 238-246(9)
Authors: Clarke B.; Chetty R.

Bartholin's Gland Carcinoma: A 15-Year Experience
pp. 247-251(5)
Authors: Cardosi R.J.; Speights A.; Fiorica J.V.; Grendys E.C.; Hakam A.; Hoffman M.S.

Effect of Hemodilution on Tissue Perfusion and Blood Coagulation during Radical Hysterectomy
pp. 252-256(5)
Authors: Santoso J.T.; Hannigan E.V.; Levine L.; Solanki D.R.; Mathru M.

Telomerase Activity in Sex Cord-Stromal Tumors of the Ovary
pp. 257-260(4)
Authors: Dowdy S.C.; O'Kane D.J.; Keeney G.L.; Boyd J.; Podratz K.C.

DNA Methylation and Ovarian Cancer - I. Analysis of CpG Island Hypermethylation in Human Ovarian Cancer Using Differential Methylation Hybridization
pp. 261-268(8)
Authors: Ahluwalia A.; Yan P.; Hurteau J.A.; Bigsby R.M.; Jung S.H.; Huang T.H.-M.; Nephew K.P.

Low Incidence of HPV DNA in Sera of Pretreatment Cervical Cancer Patients
pp. 269-272(4)
Authors: Liu V.W.S.; Tsang P.; Yip A.; Ng T.-Y.; Wong L.-C.; Ngan H.Y.S.

Thrombospondin-1 Expression in Epithelial Ovarian Carcinoma: Association with p53 Status, Tumor Angiogenesis, and Survival in Platinum-Treated Patients
pp. 273-278(6)
Authors: Alvarez A.A.; Axelrod J.R.; Whitaker R.S.; Isner P.D.; Bentley R.C.; Dodge R.K.; Rodriguez G.C.

Preoperative Hysteroscopic Assessment of Cervical Invasion by Endometrial Carcinoma: A Retrospective Study
pp. 279-282(4)
Authors: Lo K.W.K.; Cheung T.H.; Yim S.F.; Chung T.K.H.

FHIT (Fragile Histidine Triad) Gene Analysis in Cervical Intraepithelial Neoplasia
pp. 283-290(8)
Authors: Liu F.-S.; Hsieh Y.-T.; Chen J.-T.; Ho E.S.-C.; Hung M.-J.; Lin A.-J.

Expression of Latent Matrix Metalloproteinase 9 (MMP-9) Predicts Survival in Advanced Ovarian Cancer
pp. 291-298(8)
Authors: Lengyel E.; Schmalfeldt B.; Konik E.; Spathe K.; Harting K.; Fenn A.; Berger U.; Fridman R.; Schmitt M.; Prechtel D.; Kuhn W.

DNA Methylation in Ovarian Cancer - II. Expression of DNA Methyltransferases in Ovarian Cancer Cell Lines and Normal Ovarian Epithelial Cells
pp. 299-304(6)
Authors: Ahluwalia A.; Hurteau J.A.; Bigsby R.M.; Nephew K.P.

Profiling of Protein Kinases in the Neoplastic Transformation of Human Ovarian Surface Epithelium
pp. 305-311(7)
Authors: Wong A.S.T.; Kim S.O.; Leung P.C.K.; Auersperg N.; Pelech S.L.

A Study of Risk Factors for Ovarian Metastases in Stage IB-IIIB Cervical Carcinoma and Analysis of Ovarian Function after a Transposition
pp. 312-316(5)
Authors: Yamamoto R.; Okamoto K.; Yukiharu T.; Kaneuchi M.; Negishi H.; Sakuragi N.; Fujimoto S.

Phase II Trial of Oral Altretamine for Consolidation of Clinical Complete Remission in Women with Stage III Epithelial Ovarian Cancer: A Southwest Oncology Group Trial (SWOG-9326)
pp. 317-322(6)
Authors: Rothenberg M.L.; Liu P.Y.; Wilczynski S.; Hannigan E.V.; Weiner S.A.; Weiss G.R.; Hunter V.J.; Chapman J.A.; Tiersten A.; Kohler P.C.; Alberts D.S.

Liposomal Doxorubicin in Ovarian, Peritoneal, and Tubal Carcinoma: A Retrospective Comparative Study of Single-Agent Dosages
pp. 323-328(6)
Authors: Rose P.G.; Hawthorne Maxson J.; Fusco N.; Mossbruger K.; Rodriguez M.

Predictors of Complications after Inguinal Lymphadenectomy
pp. 329-332(4)
Authors: Gould N.; Kamelle S.; Tillmanns T.; Scribner D.; Gold M.; Walker J.; Mannel R.

Phase I Trial of Concomitant Vinorelbine, Paclitaxel, and Pelvic Irradiation in Cervical Carcinoma and Other Advanced Pelvic Malignancies
pp. 333-337(5)
Authors: Mundt A.J.; Rotmensch J.; Waggoner S.E.; Yamada D.; Langhauser S.C.; Fleming G.F.

Outcome of Endometrial Carcinoma Patients with Involvement of the Uterine Serosa
pp. 338-343(6)
Authors: Ashman J.B.; Connell P.P.; Yamada D.; Rotmensch J.; Waggoner S.E.; Mundt A.J.

Ovarian Epithelial Dysplasia in Relation to Ovulation Induction and Nulliparity
pp. 344-349(6)
Authors: Nieto J.J.; Crow J.; Sundaresan M.; Constantinovici N.; Perrett C.W.; MacLean A.B.; Hardiman P.J.

High Sensitivity of PCR in Situ Hybridization for the Detection of Human Papillomavirus Infection in Uterine Cervical Neoplasias
pp. 350-354(5)
Authors: Xiao Y.; Sato S.; Oguchi T.; Kudo K.; Yokoyama Y.; Saito Y.

Expanded Cytological Referral Criteria for Colposcopy in Cervical Screening: Comparison with Human Papillomavirus Testing
pp. 355-359(5)
Authors: Paraskevaidis E.; Malamou-Mitsi V.; Koliopoulos G.; Pappa L.; Lolis E.; Georgiou I.; Agnantis N.J.

Stamm Gastrostomy for Postoperative Gastric Decompression in Gynecologic Oncology Patients
pp. 360-363(4)
Authors: Hoffman M.S.; Cardosi R.J.; Lemert R.; Drake J.G.

Surgical Blood Loss in Abdominal Hysterectomy
pp. 364-366(3)
Authors: Santoso J.T.; Dinh T.A.; Omar S.; Gei A.F.; Hannigan E.V.

Weekly Intravenous Methotrexate with Folinic Acid for Nonmetastatic Gestational Trophoblastic Neoplasia
pp. 367-370(4)
Authors: Kwon J.S.; Elit L.; Mazurka J.; Moens F.; Schmuck M.L.

Long-Term Survival of Intermediate Risk Endometrial Cancer (Stage IG3, IC, II) Treated with Full Lymphadenectomy and Brachytherapy without Teletherapy
pp. 371-374(4)
Author: Fanning J.

Nodal Distribution and Its Significance in FIGO Stage IIIc Endometrial Cancer
pp. 375-379(5)
Authors: McMeekin D.S.; Lashbrook D.; Gold M.; Scribner D.R.; Kamelle S.; Tillmanns T.D.; Mannel R.

Primary Malignant Melanoma in Ovarian Cystic Teratoma
pp. 380-383(4)
Authors: Vimla N.; Kumar L.; Thulkar S.; Bal S.; Dawar R.

Endometrial Stromal Sarcoma: Objective Response to Letrozole
pp. 384-388(5)
Authors: Maluf F.C.; Sabbatini P.; Schwartz L.; Xia J.; Aghajanian C.

Hyperprolactinemia Complicating Juveline Granulosa Cell Tumor of the Ovary
pp. 389-391(3)
Authors: Santala M.; Suvanto-Luukkonen E.; Kyllonen A.; Ruokonen A.; Puistola U.

Ovarian Endodermal Sinus Tumor in a Postmenopausal Woman
pp. 392-394(3)
Authors: Oh C.; Kendler A.; Hernandez E.

Spontaneous Regression of Stage IV Clear Cell Carcinoma of the Endometrium in a Patient with Essential Thrombocytosis
pp. 395-399(5)
Authors: Parker R.; Lanvin D.; Gilks B.; Miller D.

Epithelioid Leiomyosarcoma of the Uterine Cervix
pp. 400-405(6)
Authors: Gotoh T.; Kikuchi Y.; Takano M.; Kita T.; Ogata S.; Aida S.

Limited Value of Sonohysterography for Endometrial Screening in Asymptomatic, Postmenopausal Patients Treated with Tamoxifen - To the Editor
pp. 406-406(1)
Author: Cohen I.

Reply
pp. 406-407(2)
Author: Bertelli G.

Regarding Ng et al.: Defining the Role of Adjuvant Radiotherapy for High-Risk Stage I Endometrial Patients - To the Editor
pp. 407-408(2)
Authors: Petereit D.G.; Frederickson H.

Chemotherapy in the Treatment of Locally Advanced Cervical Cancer during Pregnancy - To the Editor
pp. 409-409(1)
Author: Rose P.G.

Reply
pp. 409-410(2)
Author: Marana H.R.C.

Reply
pp. 409-409(1)
Authors: Ng T.Y.; Perrin L.C.; Nicklin J.L.; Cheuk R.; Crandon A.J.

Reply - To the Editor
pp. 410-410(1)
Authors: Barton D.P.J.; Butler-Manuel S.; Buttery L.D.K.; A'Hern R.; Polak J.M.

Reply - To the Editor
pp. 410-411(2)
Authors: Maneo A.; Landoni F.; Milani R.

Papers to Appear in Forthcoming Issues
pp. 412-412(1)